GENEGUT’s Post

In my first review paper, recently published in the European Journal of Pharmaceutical Sciences, we examine the current state of smart drug delivery capsules and how incorporating recent technological advancements could enable precise, remotely controlled drug delivery to specific regions of the GI tract. This could have a transformative impact on treating conditions like inflammatory bowel disease. 🚀 A big thank you to my co-authors Brendan Griffin, Joseph O'Shea (School of Pharmacy, UCC), Vincent Jannin (Lonza Capsules & Health Ingredients), and Paul Galvin (Tyndall National Institute) for their collaboration on this exciting work! 🤝 This review is funded by the European Union as part of the GENEGUT project, which focuses on developing a novel nanoparticle RNA therapy for the treatment of ileal Crohn’s disease. Read the article here: https://lnkd.in/dtTs7_6A Looking forward to what the future holds for precision medicine in gastrointestinal disorders! 🎯 #smartcapsule #drugdelivery #IBD #crohnsdisease #GENEGUT